NON-IMMUNOGENIC RECOMBINANT STAPHYLOKINASE VERSUS ALTEPLASE FOR PATIENTS WITH ACUTE ISCHAEMIC STROKE 4·5 H AFTER SYMPTOM ONSET IN RUSSIA (FRIDA): A RANDOMISED, OPEN LABEL, MULTICENTRE, PARALLEL-GROUP, NON-INFERIORITY TRIAL ArticleGusev E.I., Martynov M.Y., Nikonov A.A., Shamalov N.A., Semenov M.P., Gerasimets E.A., Yarovaya E.B., Semenov A.M., Archakov A.I., Markin S.S., Aksentiev S.B., Yunevich D.S., Alasheev A.M., Androfagina O.V., Bobkov V.V., Choroshavina K.V., Chefranova J.Y., Lykov Y.A., Chuprina S.E., Vorobev A.A. ...The Lancet Neurology. Том 20. 2021. С. 721-728
